Research and Clinical Trials

Title  
Millennium Pharmaceuticals NSMM-5001: A global, prospective, no-interventional, observational study of presentation, treatment patterns, and outcomes in multiple myeloma patients.
Brief Description  
Primary: Describe contemporary, real-world disease and patient presentation, therapies, and clinical outcomes in both patients with newly diagnosed and not yet relapsed MM and relapsed, refractory MM by geographic region, new diagnosis, patient attributes, disease characteristics, treatment choices and clinical outcomes.
Who may be Eligible  
Please contact us for eligibility criteria.
Speciality/Disorder  
Multiple Myeloma
Status  
OPEN
Start Date  
12/07/2016
IRB Number  
00018775
Principal Investigator  
Usmani, Saad Zafar
Contact Name  
Tulsi Patel

For More Information, Contact  Tulsi  , Patel
Phone:  980-442-2344 Fax:    
Email:  Tulsi.Patel@carolinashealthcare.org
Address:1021 Morehead Medical Drive Suite 2200 Charlotte, 28204
Close